Bentley Pharmaceuticals appoints John A. Sedor President
Bentley Pharmaceuticals, Inc. announced that it has appointed John A. Sedor as its new President, succeeding James R. Murphy, who will remain Chairman and CEO of the Company.
John A. Sedor has a 30-year track record as a successful business leader in the pharmaceutical, biotechnology and consumer products industries. Most recently, he was President and CEO of Sandoz, Inc., and he held similar positions at Verion, Inc., and Centeon, LLC. Other industry experience includes positions at Rhône-Poulenc, Rorer, Revlon Health Care Group, Armour Pharmaceutical Company, and Parke-Davis. He is a past Chairman of the International Plasma Products Industry Association, and a former board member of Quantum Homecare, Applied Immune Sciences and the National Pharmaceutical Council. A veteran of the Vietnam War, Mr. Sedor holds a Bachelor of Science degree from Duquesne University, and has studied strategic marketing at both Northwestern University's Kellogg Graduate School of Management and Harvard University. He has attended Harvard's executive forum as well.
Most read news
Topics
Organizations
Other news from the department people
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.